<strong>DEINOVE: the industrialization process of the carotenoids program enters Phase II</strong></br>News

DEINOVE: the industrialization process of the carotenoids program enters Phase II
News

News
  In November 2016, DEINOVE launched the shift from laboratory to industrial scale, accompanied by the company Processium* . The first phase of this program consisted of: Selecting and characterizing a first carotenoid that will be market-ready, validating both its biological properties and its economic potential; Optimizing the production strain and increasing the yields in the laboratory, with a view to obtaining a strain suitable for industrial production; Evaluating the various extraction processes in order to define the best one in industrial production conditions. This phase I has been conducted successfully. A first molecule has been selected for its innovative feature, with the goal of obtaining a competitive advantage on the market. DEINOVE has demonstrated its total safety, but also its antioxidant and healing properties, which position this first molecule…
Read More
News: Processium New offices in Villeurbanne

News: Processium New offices in Villeurbanne

News
Processium development comes along with the construction of new premises which will locate in the same place its team of experts and enhance its technical means with, in particular, a new technological and demonstration hall which will allow Processium to validate experimentally the processes, to produce samples and to accommodate the pilots of its customers.
Read More
News: Deinove signs a partnership with Processium to prepare for the industrialization of its carotenoid production process

News: Deinove signs a partnership with Processium to prepare for the industrialization of its carotenoid production process

News
In 2016, DEINOVE obtained proof of concept for the production of carotenoid molecules from optimized Deinococcus strains: 5 conventional molecules with known applications and identified markets; 1 new molecule, Deinoxanthin, which must undergo characterization tests and a regulatory clearance before it can be marketed. One of DEINOVE’s strategic goals is to market carotenoids in the form of ingredients directly to the industrials of its target markets. DEINOVE does not have plans to develop its own manufacturing facilities, but will subcontract production, including the large-scale fermentation, extraction, purification and formulation stages. DEINOVE therefore chose Processium, an industrial process engineering firm headquartered in Lyon that works in the chemistry and biotech fields. The experts at Processium will have two major missions with DEINOVE: developing and validating an industrial process for extracting carotenoids…
Read More